ExitValue.ai

Home / Benchmarks / Home Health

Home HealthM&A Activity

Deal flow, active acquirers, and current market trend - based on 226real disclosed M&A transactions in the home health space. Run the calculator below to price your business at current multiples.

226 disclosed deals138 with EBITDAMarket: growing

State of Home HealthM&A in 2026

The home health M&A market is tracked across 226 disclosed transactions in the ExitValue.ai database (138 with EBITDA disclosed, 218 with revenue). The current market trend is growing.

Active acquirers include Kinderhook Industries, BrightSpring Health Services, UnitedHealth Group (Optum), Extendicare Inc.. Recent named transactions: Enhabit Home Health & Hospice (2026); Amedisys Divested Assets (107 locations) (2026); Amedisys Inc. (2025).

Premium valuations in home health are driven by cms star rating 4+ (quality-bonus payments + survey advantage in any sale process); multi-county geographic density (lhc / amedisys / encompass pay for fill-in geography); diversified referral base (no single hospital system above 25% of admits).

What compresses valuations: pdgm reimbursement compression exposure (review case-mix index trend before listing); single-payer concentration above 80% (medicare-only book limits buyer pool); branch-level rn turnover above 25% annually (priced in as transition risk).

Source: SEC filings, EDGAR 8-K/S-4, and verified press releases. Run the calculator below to see the specific multiples that apply to your business.

Recent named M&A deals in home health

Most-recent disclosed transactions. Click any deal for full detail (multiples, financials, source).

Enhabit Home Health & HospiceKinderhook Industries
2026
Amedisys Divested Assets (107 locations)BrightSpring Health Services
2026
Amedisys Inc.UnitedHealth Group (Optum)
2025
CBI Home HealthExtendicare Inc.
2025
LHC / Amedisys AgenciesBrightSpring Health Services , Inc.
2025
Amedisys Agencies (TN, GA, AL)The Pennant Group, Inc.
2025

Sourced from SEC filings, EDGAR 8-K/S-4, and verified press releases.

Get an instant valuation for your home health

Backed by the same 226 disclosed transactions, adjusted for your specific size and margin.

Get your full valuation analysis

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

  • Sellability score with 5-driver breakdown and lift estimates
  • Named comparable M&A transactions in your sub-vertical
  • AI-written analysis grounded in your specific inputs
Run my valuation analysis →

What drives a premium valuation

  • CMS Star rating 4+ (quality-bonus payments + survey advantage in any sale process)
  • Multi-county geographic density (LHC / Amedisys / Encompass pay for fill-in geography)
  • Diversified referral base (no single hospital system above 25% of admits)

What compresses valuation

  • PDGM reimbursement compression exposure (review case-mix index trend before listing)
  • Single-payer concentration above 80% (Medicare-only book limits buyer pool)
  • Branch-level RN turnover above 25% annually (priced in as transition risk)

Home Health valuation: common questions

How is a home health business valued?

Home Health businesses are valued by benchmarking against comparable completed M&A transactions, then adjusting for the specific business. Owner-operator practices are typically priced on an earnings or seller-discretionary-earnings basis, while businesses at platform scale shift toward institutional earnings-multiple methodology. The ExitValue.ai engine selects the methodology that the comparable deal set actually used and adjusts for margin quality, growth, owner dependency, customer concentration, and recurring-revenue mix.

What drives home health valuation?

The biggest value levers in home health are recurring or repeat revenue, owner independence (the business runs without the founder), customer diversification (no single client dominates), a credible growth trajectory, and operating-margin quality relative to the vertical. In this space specifically, buyers pay up for cms star rating 4+ (quality-bonus payments + survey advantage in any sale process); multi-county geographic density (lhc / amedisys / encompass pay for fill-in geography); diversified referral base (no single hospital system above 25% of admits).

How many home health M&A deals are tracked?

ExitValue.ai tracks 226 disclosed home health M&A transactions, 138 with EBITDA disclosed, 218 with revenue disclosed, sourced from SEC filings, EDGAR 8-K/S-4 documents, and verified press releases and refreshed daily. Current market trend: growing.

Who buys home health businesses?

Home Health businesses are acquired by strategic acquirers (larger operators in the same space), and private-equity platforms and roll-up consolidators, and unknown. Recent named acquirers include Kinderhook Industries, BrightSpring Health Services, UnitedHealth Group (Optum), Extendicare Inc..

What is my home health business worth?

Run the ExitValue.ai home health calculator to see your business priced against the 226 disclosed home health transactions in the database. The engine applies adjustments for margin, growth, owner dependency, customer concentration, and recurring revenue mix to produce a tight range around the most-likely transaction value.

More on home health valuations